Free shipping on all orders over $ 500

Bendamustine hydrochloride

Cat. No. M2183
Bendamustine hydrochloride Structure
Synonym:

SDX-105

Size Price Availability Quantity
100mg USD 140  USD140 In stock
500mg USD 360  USD360 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Bendamustine hydrochloride (also known as SDX-105) is a DNA-damaging agent with IC50 of 50 μM. Bendamustine displays a distinct pattern of activity unrelated to other DNA-alkylating agents. Bendamustine hydrochloride activates a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Bendamustine hydrochloride (SDX-105) inhibits mitotic checkpoints and induces mitotic catastrophe. The combination of bendamustine with fludarabine led to a highly synergistic effect in inducing apoptosis, which was 150% higher than expected for bendamustine plus fludarabine. Bendamustine has been used both as sole therapy and in combination with other agents including etoposide, fludarabine, mitoxantrone, methotrexate, prednisone, rituximab and vincristine.

Chemical Information
Molecular Weight 394.72
Formula C16H21Cl2N3O2.HCl
CAS Number 3543-75-7
Form Solid
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Masiello D, et al. Expert Opin Pharmacother. Bendamustine therapy in chronic lymphocytic leukemia.

[2] Leoni LM, et al. Clin Cancer Res. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

[3] Schwänen C, et al. Leukemia. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.

Related DNA Alkylator/Crosslinker Products
LP-284

LP-284 is a potent DNA alkylating agent that kills solid tumours. LP-284 can be used in the studies of hematologic cancers with compromised DNA repair, such as mantle cell lymphoma (MCL).

4-Hydroperoxy cyclophosphamide

4-Hydroperoxy cyclophosphamide, the active metabolite form of the precursor Cyclophosphamide, cross-links DNA and induces T-cell apoptosis independent of caspase receptor activation, as well as activating the mitochondrial death pathway through the generation of reactive oxygen species (ROS). It can be used in studies related to rheumatoid arthritis and autoimmune diseases.

Diaziquone

Diaziquone is a water-soluble synthetic aziridinyl benzoquinone that selectively alkylates and cross-links DNA, inhibits DNA replication, induces apoptosis, and inhibits the proliferation of tumor cells, with potential antitumor activity.

Semustine

Semustine is a methylated derivative of Carmustine and also a DNA alkylating agent, which can form covalent bonds with nucleophilic centers in DNA, causing depurination, base pair miscoding, strand breaks, and DNA-DNA cross-linking, and has antitumor activity.

Methyl methanesulfonate

Methyl methanesulfonate is a SN2-type alkylating agent that primarily methylates the nitrogen atom in purines and has apoptosis-inducing effects.

  Catalog
Abmole Inhibitor Catalog




Keywords: Bendamustine hydrochloride, SDX-105 supplier, DNA Alkylator/Crosslinker, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.